Modern strategies for the treatment of type 2 diabetes in patients with stable coronary artery disease. Old goals, new opportunities (literature review)

Abstract

The review summarizes and analyzes the available literature to provide information to clinicians about the best treatment strategies for type 2 diabetes in stable coronary artery disease. This data should help health care professionals make decisions in routine practice. 2023 European and Russian guidelines on type 2 diabetes suggest giving preference to glucose-lowering agents with proven benefits for the cardiovascular system, followed by drugs with proven safety for the cardiovascular system.

Keywords

• guidelines
• diabetes
• stable coronary artery disease
• cardiovascular risk assessment
• glucagon-like peptide-1 receptor antagonists
• sodium-glucose cotransporter 2 inhibitors